← Back to Clinical Trials
Recruiting NCT07808476

NCT07808476 Efficacy Of Gross Myofascial Release With Neural Mobilization Versus Neural Mobilization Alone On Pain, Functional Limitations, And Cervical Range Of Motion In Cervical Radiculopathy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07808476
Status Recruiting
Phase —
Sponsor Ibadat International University, Islamabad
Condition Cervical Radiculopathy
Study Type INTERVENTIONAL
Enrollment 44 participants
Start Date 2026-07-10
Primary Completion 2026-11-15

Eligibility & Interventions

Sex All sexes
Min Age 25 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
Gross Myofascial Release + Neural MobilizationNeural Mobilization

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 44 participants in total. It began in 2026-07-10 with a primary completion date of 2026-11-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a randomized control trial aims to evaluate the efficacy of gross myofascial release with neural mobilization versus neural mobilization alone on pain, functional limitations, and cervical range of motion in cervical radiculopathy. Cervical radiculopathy, is characterized by neck pain, pain radiating down the arm, numbness, tingling, weakness of muscles and functionality limitations with compression or irritation of the cervical nerve root due to cervical spondylosis, cervical disc herniations or degeneration of the cervical spine leading to cervical radiculopathy and the diminished quality of life from decreased day-to-day functional capacity and productivity at work. The study will evaluate pain, functional limitations, and cervical range of motion.

Eligibility Criteria

Inclusion Criteria: * Male and female patients aged between 25-55 years * Presence of chronic neck pain radiating to one upper limb * Positive Upper Limb Tension Test-I (Median nerve) * Patients having pain, numbness, tingling, or paresthesia in the cervical nerve root distribution. * Symptom's duration of at least 4 weeks Exclusion Criteria: * Patients with cervical myelopathy * History of cervical spine fracture, tumor, infection, or malignancy * Previous cervical spine surgery * Severe osteoporosis or inflammatory joint disease * Presence of systemic neurological disorders such as multiple sclerosis or stroke * Patients with severe cervical instability or vertebral artery insufficiency * Recent physiotherapy treatment for cervical radiculopathy within the last 3 months

Contact & Investigator

Central Contact

komal hameed, MSPT

✉ komal.hamees4455@gmail.com

📞 +923315798880

Principal Investigator

salma bibi

STUDY CHAIR

Ibadat International University, Islamabad

Frequently Asked Questions

Who can join the NCT07808476 clinical trial?

This trial is open to participants of all sexes, aged 25 Years or older, up to 55 Years, studying Cervical Radiculopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07808476 currently recruiting?

Yes, NCT07808476 is actively recruiting participants. Contact the research team at komal.hamees4455@gmail.com for enrollment information.

Where is the NCT07808476 trial being conducted?

This trial is being conducted at Peshawar, Pakistan.

Who is sponsoring the NCT07808476 clinical trial?

NCT07808476 is sponsored by Ibadat International University, Islamabad. The principal investigator is salma bibi at Ibadat International University, Islamabad. The trial plans to enroll 44 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology